Saltar al contenido principal

Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America

  • 1 Edición, Volumen 29-2 - 14 de abril de 2015
  • Última edición
  • Autor: Joaquim Bellmunt
  • Idioma: Inglés

This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and… Leer más

Descripción

This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 29-2
  • Publicado: 3 de junio de 2015
  • Idioma: Inglés

Sobre el autor

JB

Joaquim Bellmunt

Afiliaciones y experiencia
Director, Bladder Cancer Center Dana-Farber Cancer Institute Dana-Farber/Brigham and Women's Cancer Center Associate Professor, Harvard Medical School